Sat Kartar Life Limited · NSE:SATKARTAR
Sat Kartar Life — Sat Kartar Shopping — H2 FY25 Earnings Presentation
38 slides from Sat Kartar Life's earnings presentation, May 17, 2025
Slide 1: Regulation 30 intimation letter to NSE
Date: 17.05.2025 To, The Manager Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai-400051 SYMBOL: SATKARTAR ISIN: INE0NB801022 Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirem
Slide 2: Sat Kartar Shopping Ltd Investor Presentation H2FY25
Sat Kartar Shopping Ltd Revolutionizing Wellness with Ayurveda Investor Presentation H2FY25
Slide 3: Safe Harbour Statement
SAFE HARBOUR STATEMENT This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sat Kartar Shopping Limited (Sat Kartar, The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 4: Charaka Samhita: Vision and Mission
Charaka Samhita The Foundation of Ayurveda Charak Samhita is an ancient and foundational text in the field of Ayurveda, the traditional system of medicine that originated in India over 3,000 years ago. Attributed to the sage Charaka, the text is one of the earliest and most comprehensive compilation
Slide 5: Ayurveda, The Science of Life
Ayurveda, The Science of Life
Slide 6: About Sat Kartar
ABOUT SAT KARTAR At Sat Kartar Shopping, we are dedicated to empowering individuals to embrace a healthier, more balanced lifestyle through the timeless wisdom of Ayurveda. As a modern Ayurveda healthcare company, we blend Delivering traditional Ayurvedic knowledge with contemporary research to deli
Slide 7: Sat Kartar: A Snapshot
SAT KARTAR: A SNAPSHOT 1000+ 60+ Formulations are 16+ 750+ Team Strength SKUs approved by the Remedial Call Executives Ministry of AYUSH Solutions Pan-India Presence 97.6% 98.3% In-House R&D 20,000 ROE ROCE Daily Unique Leads 6
Slide 8: Our Care and Support to Your Problems
OUR CARE AND SUPPORT TO YOUR PROBLEMS REMEDIES TO 16+ PROBLEMS 80% Revenue Sexual Diabetes Piles De- Bone & Contribution Wellness Care Addictions Joints 20% PCOS Respiratory Hair Liver Infertility Mind Immune Lungs Personal Revenue PCOD Support Care Care Support Care Support Care Care Contribution 7
Slide 9: Sat Kartar's Growth Formula
SAT KARTAR’S GROWTH FORMULA Cash Efficiency + Scale = Profitable Growth ASSET-LIGHT Company's major focus is to be asset MODEL light and generate higher cashflows. NEGATIVE LEVERAGING DATABASE OF WORKING 30 MILLION CONSUMERS CAPITAL CYCLE Grow without heavy assets keeping capital free and margins st
Slide 10: A Pan-India Team Driving Growth in Natural Wellness
A PAN-INDIA TEAM DRIVING GROWTH IN NATURAL WELLNESS Ayurveda First 750+ Strong Workforce Delhi Team: 530+ Noida Team: 230+ A dedicated focus on Ayurveda makes us a trusted player in the natural wellness space. A Team That Multilingual Reach Multilingual Support Teams Speaks Languages: Hindi We conne
Slide 11: Healing Across Bharat
HEALING ACROSS BHARAT North India 70% We operate and ensure availability of our products all over India North India : 70% We deliver to the parts of the country Our highest revenue comes from: even where e-commerce fails to deliver Tamil Nadu 23% We serve to more than 11,600 Pincodes Uttar Pradesh 9
Slide 12: Our Growth Strategy
OUR GROWTH STRATEGY Feedback-Driven Product Innovation Leveraging Consumer Data to Personalize, Predict, and Perform Demand Consumer Forecasting & interaction data is Lead Intelligence Inventory continuously Engine for Alignment: looped into product Real-Time Conversion We use analytics to developme
Slide 13: Way Forward: 40-50% CAGR
WAY FORWARD We're maximizing the value of our unique Pincodes that we customer database by implementing deliver to personalized engagement strategies. 7501 11,600 We’re penetrating the most underserved regions of India, ensuring Ayurveda reaches Pincodes that we every pincode, no matter how remote.
Slide 14: Outlook Vision 2028
OUTLOOK VISION 2028 FY28 FY25 REVENUE : REVENUE: 163 CRORES 500 CRORES PAT MARGIN: PAT MARGIN: 6% ORGANIC GROWTH 12% EXPANSION INTO NEW GEOGRAPHY FORAY INTO NEW PRODUCTS INORGANIC ACQUISITIONS 13
Slide 15: Utilization of IPO Proceeds
UTILIZATION OF IPO PROCEEDS FUNDS RAISED DURING IPO AMOUNTED TO 33.8 CRORE AREAS OF UTILIZATION Unidentified Acquisition Marketing and Advertisement Utilised Capital Expenditures 8.64 Cr Investment In Technology General Corporate Purposes (GCP) IPO Issue expenses 25.16 Cr Unidentified Acquisitions 5
Slide 16: Keeping the Spirit of Ayurveda Alive
Keeping the Spirit of Ayurveda Alive
Slide 17: Our Journey So Far - From Roots to Reach
OUR JOURNEY SO FAR - From Roots to Reach 2012 2013-2016 2018 2022 2024 Jan 2025 Company TV Marketing Digital Marketing Revenue IPO Application IPO Launch Incorporation Push Initiation Milestone: post Revenue 50 Crores milestone of 100 Crores 16
Slide 18: From the Promoters Desk
FROM THE PROMOTERS DESK FY25 was a defining year in our journey of building a business that is not only profitable but built for enduring scalability and capital efficiency. At Sat Kartar Shopping Ltd., we are driven by a singular ideology—to create ventures that churn capital efficiently, generate
Slide 19: From Research to Delivery: Our Product Journey
FROM RESEARCH TO DELIVERY: Our Product Journey Initial market analysis Medical formulations Regulatory Launching product Final delivery to and insights received for evaluation submission for marketing customers approval campaigns Market Formulations Formulations developed Marketing of Delivery of Re
Slide 20: Asset Light Business Model
ASSET LIGHT BUSINESS MODEL FOCUSING ON ASSET LIGHT BUSINESS MODEL AND HIGHER RETURN RATIOS Strategic Contract manufacturing We follow a strategic contract manufacturing approach: Partnering with trusted third-party Quality Assurance manufacturers who bring scale, Through robust contracts, we retain
Slide 21: Our Esteemed Management
OUR ESTEEMED MANAGEMENT Manprit Singh Chadha Pranav Singh Chadha Simrati Kaur Promoter and COO Promoter & Director Promoter & Director Mr. Manprit Singh Chadha is a Chartered Accountant by profession, with experience of more than 30 years in the Pranav has over 7 years of experience in digital Simra
Slide 22: Bridging Ancient Wisdom with Modern Science
BRIDGING ANCIENT WISDOM WITH MODERN SCIENCE Our team of Medical experts Dr. Hindika Bhagat Dr. Geeta Pathak Specialization: Infertility Counselor, Sexual Specialization: Stress management, Health, Men's Health, Respiratory Issues, Hair Women's Health Care and Personal Wellness Experience: 7+ years E
Slide 23: True Legacy Of Ayurveda
True Legacy Of Ayurveda
Slide 24: What if the answers to modern health problems were already written 5,000 years ago?
What if the answers to modern health problems were already written 5,000 years ago? Ayurveda helps us reconnect with our roots, our bodies, and nature. Rooted in 5,000 years of wisdom, it offers timeless healing that aligns with who we are at our core. Ayurveda solves most health diseases by recogni
Slide 25: Product Portfolio
PRODUCT PORTFOLIO Product Portfolio Specific problem led Lifestyle led Curative niche therapeutic area Areas Addiction Sexual Wellness Piles Immunity Care Diabetes Hair fall Personal Care Bone and Join pain Mind Care PCOS Respiratory Support PCOD 24
Slide 26: Product Portfolio
PRODUCT PORTFOLIO Addiction Sexual Wellness Piles Suppresses addiction Boosts testosterone & increases sperm count. Controls bleeding within 7 cravings. Stimulates the nervous system. to 10 days Purifies and detoxifies Provides stamina and boosts energy. Relieves pain and blood Prolongs intercourse.
Slide 27: Product Portfolio
PRODUCT PORTFOLIO Others Diabetes Bones and Joints Fertility: Nari Jeevan Stimulates secretion from Pancreatic beta -Cells Provides relief from Jyoti manages PCOD Boosts acceptance of glucose metabolizing muscle stiffness Immunity: Ayush Kwath hormones. Normalises blood sugar. Helps reduce revitalis
Slide 28: What Our Customers Say About Us
WHAT OUR CUSTOMERS SAY ABOUT US Seeing my son trapped into addiction I A miraculous buy! The hair oil works from I've been using Aadved Sleep for a month, was disheartened but Addiction Killer the 1st application itself. Flowy, soft, less- and it has greatly improved my sleep Tablets really helped u
Slide 29: Where Wellness meets Personalised Care
Where Wellness meets Personalised Care
Slide 30: Our Premium Wellness Brand
OUR PREMIUM WELLNESS BRAND VENTURING INTO HIGH MARGIN PRODUCT VERTICALS ~ Vedabay Vitili-Go Vedabay Testo Vedabay Safed Musli Vedabay Vedabay Ayush 82 Build Psory Sys Vedabay Vedabay Lungs Vedabay De- Vedabay Liver Detox Stop Piles Glutathione Detox Varicose Tablets 29
Slide 31: Industry Overview
Industry Overview
Slide 32: Industry Overview
INDUSTRY OVERVIEW What has changed post-COVID? India’s Ayurvedic Products Market Size Rising Consumer Preference Before and during COVID, a growing preference for natural and holistic ~ $9.5Billion health solutions steadily drove the Ayurveda industry's expansion. 06% . 16 of AGR Pandemic Health Awa
Slide 33: Financials
Financials
Slide 34: Standalone Profit & Loss
STANDALONE PROFIT & LOSS (₹ in Crores) H2FY25 H2FY24 YoY % FY25 FY24 YoY % Revenue from Operations 87.13 74.77 16.53 162.92 127.91 27.37 Raw material cost 4.86 5.28 - 9.00 9.03 - Employee Expenses 13.72 15.70 - 27.60 29.59 - Other Expenses 59.95 47.97 - 112.09 79.05 - EBITDA 8.60 5.83 47.51 14.23 10
Slide 35: Balance Sheet
BALANCE SHEET (₹ in Crores) Particulars Mar 2024 Mar 2025 Equity Capital 3 16 Reserves 7 36 Borrowings 2 6 Other Liabilities 11 6 Total Liabilities 22 64 Fixed Assets 3 6 CWIP 0 0.28 Investments 2 1 Other Assets 18 56 Total Assets 22 64 34
Slide 36: Key Financial Highlights
KEY FINANCIAL HIGHLIGHTS 162.92 14.23 127.91 10.24 87.13 8.60 74.77 (₹ in Crores) REVENUE 5.83 (₹ in Crores) EBITDA H2FY25 H2FY24 FY25 FY24 H2FY25 H2FY24 FY25 FY24 9.87 6.84 8.73 6.00 7.80 8.00 4.96 4.92 EBITDA MARGIN PAT MARGIN (%) (%) H2FY25 H2FY24 FY25 FY24 H2FY25 H2FY24 FY25 FY24 35
Slide 37: Market Statistics
MARKET STATISTICS NSE-SME Code SATKARTAR PUBLIC PROMOTERS Market Capitalization ₹269 Cr. 26.65% IPO Listing Date January 17, 2025 63.34% IPO Issue Price ₹81 3.70% DIIs Current Market Price ₹171 6.31% 52W High/Low ₹ 242/130 FIIs Number of Equity Shares ₹ 1.57 Cr. Industry Ayurveda/ Healthcare Note: M
Slide 38: Get in touch
Get in touch info@satkartar.in DHVIJ PATEL | AYUSH DIVECHA G12-14, 7th Floor- Commerce Centre, Mumbai- 400034 Email : ir@merlincapital.co.in Contact : +91 81048 55515